We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Determines Review Periods for Six Branded Drugs
FDA Determines Review Periods for Six Branded Drugs
July 19, 2011
A slew of brand drugmakers have sought patent term extensions in the last month, hoping to extend patent protection on six products.